Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pullen

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Nature Medicine|October 3, 2018
Renal compartment-specific genetic variation analyses identify new pathways in chronic kidney diseaseChengxiang Qiu, Shizheng Huang, Jihwan Park, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 12, 2022
The Novel, Clinical-Stage Soluble Guanylate Cyclase Activator BI 685509 Protects from Disease Progression in Models of Renal Injury and DiseaseGlenn A Reinhart, Paul C Harrison, Kathleen Lincoln, et al.
Nature Medicine|February 21, 2017
Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in micePazit Beckerman, Jing Bi-Karchin, Ae Seo Deok Park, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2008
5-Aminomethyl-1H-benzimidazoles as orally active inhibitors of inducible T-cell kinase (Itk)Michael P Winters, Darius J Robinson, Hnin Hnin Khine, et al.
Nature Genetics|August 13, 2021
Mapping the genetic architecture of human traits to cell types in the kidney identifies mechanisms of disease and potential treatmentsXin Sheng, Yuting Guan, Ziyuan Ma, et al.
Bioorganic & Medicinal Chemistry Letters|February 28, 2009
5-Aminomethylbenzimidazoles as potent ITK antagonistsDoris Riether, Renée Zindell, Jennifer A Kowalski, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2008
Discovery, SAR and X-ray structure of 1H-benzimidazole-5-carboxylic acid cyclohexyl-methyl-amides as inhibitors of inducible T-cell kinase (Itk)Kevin J Moriarty, Hidenori Takahashi, Steven S Pullen, et al.
Nature Genetics|July 24, 2024
Single-cell multi-omic and spatial profiling of human kidneys implicates the fibrotic microenvironment in kidney disease progressionAmin Abedini, Jonathan Levinsohn, Konstantin A Klötzer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2019
In vivo selective inhibition of TRPC6 by antagonist BI 749327 ameliorates fibrosis and dysfunction in cardiac and renal diseaseBrian Leei Lin, Damian Matera, Julia F Doerner, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Nature Medicine|October 3, 2018
Renal compartment-specific genetic variation analyses identify new pathways in chronic kidney diseaseChengxiang Qiu, Shizheng Huang, Jihwan Park, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 12, 2022
The Novel, Clinical-Stage Soluble Guanylate Cyclase Activator BI 685509 Protects from Disease Progression in Models of Renal Injury and DiseaseGlenn A Reinhart, Paul C Harrison, Kathleen Lincoln, et al.
Nature Medicine|February 21, 2017
Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in micePazit Beckerman, Jing Bi-Karchin, Ae Seo Deok Park, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2008
5-Aminomethyl-1H-benzimidazoles as orally active inhibitors of inducible T-cell kinase (Itk)Michael P Winters, Darius J Robinson, Hnin Hnin Khine, et al.
Nature Genetics|August 13, 2021
Mapping the genetic architecture of human traits to cell types in the kidney identifies mechanisms of disease and potential treatmentsXin Sheng, Yuting Guan, Ziyuan Ma, et al.
Bioorganic & Medicinal Chemistry Letters|February 28, 2009
5-Aminomethylbenzimidazoles as potent ITK antagonistsDoris Riether, Renée Zindell, Jennifer A Kowalski, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2008
Discovery, SAR and X-ray structure of 1H-benzimidazole-5-carboxylic acid cyclohexyl-methyl-amides as inhibitors of inducible T-cell kinase (Itk)Kevin J Moriarty, Hidenori Takahashi, Steven S Pullen, et al.
Nature Genetics|July 24, 2024
Single-cell multi-omic and spatial profiling of human kidneys implicates the fibrotic microenvironment in kidney disease progressionAmin Abedini, Jonathan Levinsohn, Konstantin A Klötzer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2019
In vivo selective inhibition of TRPC6 by antagonist BI 749327 ameliorates fibrosis and dysfunction in cardiac and renal diseaseBrian Leei Lin, Damian Matera, Julia F Doerner, et al.
Pageof 7